SCHEMBL20868304

SCHEMBL20868304

COc1ccc(-c2cc(=O)c3c(C)cc(O)cc3o2)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.79
▸ MEN1 O00255 7/20 0.79
▸ KMT2A Q03164 7/20 0.79
▸ CYP3A4 P08684 7/20 0.79
▸ TP53 P04637 5/20 0.79
▸ CYP2C9 P11712 5/20 0.79
▸ CYP2C19 P33261 5/20 0.79
▸ ALDH1A1 P00352 5/20 0.79
▸ FLT3 P36888 4/20 0.79
▸ NPC1 O15118 4/20 0.79
▸ RAB9A P51151 3/20 0.79
▸ SMN1; SMN2 Q16637 3/20 0.79
▸ CYP2D6 P10635 3/20 0.79
▸ MAOB P27338 2/20 0.79
▸ KCNA5 P22460 2/20 0.79
▸ KCNH2 Q12809 2/20 0.79
▸ IP6K2 Q9UHH9 2/20 0.79
▸ MAPK1 P28482 2/20 0.79
▸ CYP1B1 Q16678 2/20 0.79
▸ USP2 O75604 1/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acacetin SCHEMBL29387049 0.88 CYP1B1 (1.00) MAPTMEN1KMT2ACYP3A4TP53
Acacetin SCHEMBL107712 0.88 CYP1B1 (1.00) MAPTMEN1KMT2ACYP3A4TP53
SCHEMBL14749128 0.88 MAPT (0.73) MAPTMEN1KMT2ACYP3A4TP53
Acacetin SCHEMBL28278297 0.87 CYP1B1 (0.97) MAPTMEN1KMT2ACYP3A4TP53
SCHEMBL4279323 0.87 ABCB1 (0.80) MAPTMEN1KMT2ACYP3A4TP53
SCHEMBL20664412 0.86 ADORA3 (0.76) MAPTMEN1KMT2ACYP3A4TP53
Apigenin Dimethylether SCHEMBL1176691 0.85 MAOB (1.00) MAPTMEN1KMT2ACYP3A4TP53
Apigenin Dimethylether SCHEMBL29392759 0.85 MAOB (1.00) MAPTMEN1KMT2ACYP3A4TP53
SCHEMBL16521507 0.84 MAPT (0.71) MAPTMEN1KMT2ACYP3A4TP53
SCHEMBL20868305 0.84 CYP1B1 (0.82) MAPTMEN1KMT2ACYP3A4TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190100549-A1 FLAVONOIDE-TYPE COMPOUNDS BEARING AN O-RHAMNOSYL RESIDUE UNIVERSITAET HAMBURG (DE) 2019-04-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190100549-A1 FLAVONOIDE-TYPE COMPOUNDS BEARING AN O-RHAMNOSYL RESIDUE LRAT, TYR, CUTA MAPT 846/4885MEN1 1039/4885KMT2A 2491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback